Viral Infos

Information That Matters

Kelly Clarkson Did not Take Ozempic for Weight Loss 
Entertainment Global Trends

Kelly Clarkson Did not Take Ozempic for Weight Loss 

Kelly Clarkson is happy with weight loss, and she admits to using weight loss medication. However, the singer clarified that she had never consumed Ozempics to meet the goal.

Kelly Clarkson, who lost an estimated 60 pounds weight in the last few months, has finally revealed the helping medication. She admits to the speculations about consuming weight loss pills to lose weight. However, at the same time, Kelly revealed that she did not consume the fancy weight loss medication Ozempic.

In a recent episode of “The Kelly Clarkson Show,” the singer revealed the practices involved in her weight loss journey and addressed speculations about the use of Ozempic in her weight loss journey. The hitmaker agreed that she took a Type II diabetes weight-loss drug, Mounjaro.

However, even after revealing the drug’s name and admitting its use, the singer did not talk more about the drug. Kelly Clarkson also said she was initially not ready to take weight loss pills. She had a fear of the adverse effects of using weight loss pills, especially keeping her thyroid complications in mind. 

However, after taking some opinions and self-thinking, she decided to join the treatment to help her body with the breakdown of sugar. 

While talking about her weight loss journey, Kelly Clarkson revealed that she was happy even with her heaviest weight. She indicates that her weight loss journey was not driven solely by dissatisfaction with her body but rather by a personal realization and decision.

In addition, Ricki Lake has lost 35 pounds, while her husband, Ross Burningham, lost about five without taking any medications. 

How much weight has Kelly Clarkson lost?

Clarkson has not disclosed the exact amount of weight she lost, but it is estimated that she lost about 60 pounds. She also involved some weight loss practices, diet and exercies to lose the weight.

We will inform you if any further updates come on the topic. 



Your email address will not be published. Required fields are marked *

Enable Notifications Accept No thanks